Independence Capital Asset Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Independence Capital Asset Partners’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-536,210	Closed	-$5.63M	–	94
2015 Q1	$5.63M	Sell	536,210 -115,699	-18%	-$1.58M	0.88%	41
2014 Q4	$7.84M	Sell	651,909 -136,655	-17%	-$2.08M	1.08%	44
2014 Q3	$13.5M	Buy	788,564 +751,973	+2,055%	+$10.9M	1.88%	24
2014 Q2	$442K	Buy	+36,591	New	+$347K	0.06%	73

Other funds holding BDSI

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Independence Capital Asset Partners's BDSI Position: Q2 2015 in Review

Independence Capital Asset Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2015, closing a stake of 536,210 shares — an estimated $5.63M sold.

Independence Capital Asset Partners first reported a position in BDSI in Q2 2014 and held it in 4 quarters. The position peaked at $13.5M in Q3 2014. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2015.

Independence Capital Asset Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2015 after selling out during the quarter.
Independence Capital Asset Partners sold 536,210 BioDelivery Sciences International, Inc. shares in Q2 2015, an estimated $5.63M.
Independence Capital Asset Partners first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 4 quarters.
Independence Capital Asset Partners's BioDelivery Sciences International, Inc. position peaked at $13.5M in Q3 2014.
143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2015.

Based on Independence Capital Asset Partners's 13F filing for Q2 2015, filed 13 Aug 2015.